HK1206267A1 - 穩定化的吡鉑口服劑型 - Google Patents

穩定化的吡鉑口服劑型

Info

Publication number
HK1206267A1
HK1206267A1 HK15106959.9A HK15106959A HK1206267A1 HK 1206267 A1 HK1206267 A1 HK 1206267A1 HK 15106959 A HK15106959 A HK 15106959A HK 1206267 A1 HK1206267 A1 HK 1206267A1
Authority
HK
Hong Kong
Prior art keywords
dosage form
oral dosage
stabilized picoplatin
picoplatin oral
stabilized
Prior art date
Application number
HK15106959.9A
Other languages
English (en)
Inventor
‧利
‧普羅西夏伊
‧王
‧吉安多米尼科
Original Assignee
Encarta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Encarta Inc filed Critical Encarta Inc
Publication of HK1206267A1 publication Critical patent/HK1206267A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15106959.9A 2007-02-09 2015-07-21 穩定化的吡鉑口服劑型 HK1206267A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88917107P 2007-02-09 2007-02-09
US88968107P 2007-02-13 2007-02-13

Publications (1)

Publication Number Publication Date
HK1206267A1 true HK1206267A1 (zh) 2016-01-08

Family

ID=39682046

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106959.9A HK1206267A1 (zh) 2007-02-09 2015-07-21 穩定化的吡鉑口服劑型

Country Status (12)

Country Link
EP (1) EP2114418A4 (zh)
JP (1) JP2010518089A (zh)
KR (1) KR20090109129A (zh)
CN (2) CN101678046A (zh)
AU (1) AU2008214202A1 (zh)
BR (1) BRPI0806418A2 (zh)
CA (1) CA2677640A1 (zh)
HK (1) HK1206267A1 (zh)
IL (1) IL200262A0 (zh)
MX (1) MX2009008488A (zh)
RU (1) RU2009133446A (zh)
WO (1) WO2008097661A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8168661B2 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20120148661A1 (en) * 2009-04-15 2012-06-14 Poniard Pharmaceuticals, Inc. High bioavailability oral picoplatin anti-cancer therapy
AU2015263884B2 (en) * 2014-05-23 2019-11-14 Mingsight Pharmaceuticals, Inc. Treatment of autoimmune disease
CN107778331B (zh) * 2016-08-27 2020-06-30 鲁南制药集团股份有限公司 一种甲啶铂的提纯方法
CN108864177B (zh) * 2018-04-20 2020-07-28 公安部物证鉴定中心 [2h3]-1-甲氨基-2-苯基丙烷的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
HUP0204139A3 (en) * 2000-02-16 2003-07-28 Yamanouchi Pharma Co Ltd Use of n-[6-methoxi-5-(2-methoxiphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]-2phenyl-etienesulfonamide for producing pharmaceutical composition using for reducing pain in an endothelin-induced disease
WO2002085385A2 (en) * 2001-04-23 2002-10-31 Nucryst Pharmaceuticals Corp. Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa
DE10141528B4 (de) * 2001-08-24 2006-08-10 Faustus Forschungs Cie. Translational Cancer Research Gmbh Platin(II)- und Platin(IV)-Komplexe und ihre Verwendung
US20050119238A1 (en) * 2002-03-01 2005-06-02 Baron John A. Compositions and methods for preventing sporadic neoplasia in colon
WO2004006859A2 (en) * 2002-07-16 2004-01-22 Sonus Pharmaceuticals, Inc. Platinum compound
CN1681478A (zh) * 2002-08-02 2005-10-12 川塞夫有限公司 铂聚集体及其制备方法
CA2559722A1 (en) * 2004-03-18 2005-09-29 Transave, Inc. Administration of cisplatin by inhalation
US20060205810A1 (en) * 2004-11-24 2006-09-14 Schering Corporation Platinum therapeutic combinations

Also Published As

Publication number Publication date
AU2008214202A1 (en) 2008-08-14
BRPI0806418A2 (pt) 2011-09-06
EP2114418A1 (en) 2009-11-11
CA2677640A1 (en) 2008-08-14
MX2009008488A (es) 2010-01-15
IL200262A0 (en) 2010-04-29
JP2010518089A (ja) 2010-05-27
KR20090109129A (ko) 2009-10-19
CN104288119A (zh) 2015-01-21
RU2009133446A (ru) 2011-03-20
EP2114418A4 (en) 2013-01-09
WO2008097661A1 (en) 2008-08-14
CN101678046A (zh) 2010-03-24

Similar Documents

Publication Publication Date Title
IL251175A0 (en) Stabilized dosage of picoplatin
IL206159A0 (en) Oral pharmaceutical dosage forms
ZA201006029B (en) Pharmaceutical dosage form
EP2178893A4 (en) ORAL FORMULATIONS FOR PICOPLATIN
ZA201005015B (en) Solid pharmaceutical dosage form
ZA201101523B (en) Linaclotide-containing formulations for oral administration
PT2077729E (pt) Formas orais probióticas
HK1154484A1 (zh) 口服組合物
GB0710439D0 (en) Oral dosage form
HK1206267A1 (zh) 穩定化的吡鉑口服劑型
IL205160A0 (en) Oral dosage forms comprising licarbazepine acetate
PL2167033T4 (pl) Podawana raz dziennie doustna postać dawkowania zawierająca takrolimus
EP2226071A4 (en) COMPOSITIONS FOR ORAL ADMINISTRATION
ZA200903858B (en) Pharmaceutical dosage form
HK1137363A1 (en) Novel dosage form
GB0822124D0 (en) Oral dosage form
EP2337565A4 (en) STABLE SOLID ORAL CO DOSAGE FORMULATIONS
ZA201102405B (en) Pharmaceutical composition for oral administration
HK1115054A1 (en) Preparation for oral administration
GB0704123D0 (en) Dosage form